1.
Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 19];2(S1):S54. Available from: https://skin.dermsquared.com/skin/article/view/289